1. All Products
  2. E 275mg / H 75mg / R 150mg, tab., blister
Public Pricelist

E 275mg / H 75mg / R 150mg, tab., blister

https://medicalguidelines.msf.org/en/node/401
https://unicat.msf.org/cat/product/12008
STD DORAEHRI1T1

Valid Article

Former Code(s): -X DORARHEF01T
6.2.5 - Antituberculosis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J04AM07
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

ETHAMBUTOL (E) / ISONIAZID (H) / RIFAMPICIN (R)

Therapeutic Action

Fixed-dose combination (FDC) of two antituberculosis bactericidals and one antituberculosis bacteriostatic (ethambutol)

Indications

Drug-Sensitive tuberculosis (DS-TB)

Instructions for use

Blister packaging is the packaging of choice for antituberculosis medicines due to the unstable nature of some of them when exposed to higher temperatures and humidity.

Bulk packaging (hospital packs) should only be used in special circumstances or in case of unexpected problems in availability of the blister presentation.

The quantity to be ordered is calculated per tablet, not per blister.

Storage

Below 25°C ‐ Protect from sunlight ‐ Protect from humidity